Drug recall · June 21, 2017
Montelukast Sodium Oral Granules recall
Why: Failed Impurities/Degradation Specifications; out of specification results for Sulphoxide Impurity and Total Impurities
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Montelukast Sodium Oral Granules, 4 mg pouch, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-6040-93
- Lots / codes
Batch 3074707, exp 02/2018
- Quantity
- 11,624 pouches
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- Nationwide
- Initiated
- May 9, 2017 · Voluntary: Firm initiated
- Classified
- June 15, 2017
- Reported
- June 21, 2017
- Ended
- February 14, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Montelukast
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.